HAS1 and nonpapillary renal cell carcinoma: qRT-PCR results indicate that the mRNA expression of HAS1 was elevated in CD44-overexpressing ccRCC cells (Figure 4C), conversely, the downregulation of CD44 resulted in a contrary trend in HAS1 expression (Supplementary Figure S3).